You are here

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Original research
T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion

 

Online download statistics by month:

Online download statistics by month: March 2022 to December 2025

AbstractFullPdf
Mar 2022774808313
Apr 2022741772191
May 2022340345100
Jun 2022283302107
Jul 202231231674
Aug 2022336352103
Sep 202226726893
Oct 202229430685
Nov 202228128270
Dec 202219420155
Jan 202379780193
Feb 202352552897
Mar 202341741985
Apr 202315215270
May 202314814859
Jun 202323523556
Jul 202317017155
Aug 202312412440
Sep 202314014572
Oct 202325326277
Nov 202317219767
Dec 202313314059
Jan 2024878761
Feb 202411711756
Mar 2024191195103
Apr 202414514442
May 202413313457
Jun 202415415755
Jul 202412112354
Aug 20248986176
Sep 202497100161
Oct 202414314352
Nov 202414514659
Dec 202413313750
Jan 202512512550
Feb 202514614649
Mar 202512712748
Apr 202515715864
May 2025969748
Jun 2025646433
Jul 2025110
Dec 2025550
Total936495663239